About
Our Company

Management

Board of Directors

Scientific Advisory Board

Partners

About TScan

TScan is a clinical-stage biopharmaceutical company dedicated to changing lives by discovering new cancer targets and developing safe and effective T cell therapies for patients.
Technology
Our Approach

TargetScan

ReceptorScan

SafetyScan

T-Integrate Cell Engineering

Publications

Technology

TScan’s therapeutic approach is based on the central premise that we can learn from patients who are winning their fight against cancer in order to treat those who are not.
Investors and Media
Pipeline
Careers

Unleash immunity

TScan is a clinical-stage biopharmaceutical company dedicated to creating life-changing T cell therapies for patients by unleashing the untapped potential of the human immune system.

How We're Different

News

TScan Therapeutics Named Top Place to Work by The Boston Globe for Two Consecutive Years

News

TScan Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

News

Unleash immunity

TScan Therapeutics Named Top Place to Work by The Boston Globe for Two Consecutive Years

TScan Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

TScan Therapeutics Presents Phase 1 Trial Design for Solid Tumor Program at the Society for Immunotherapy of Cancer 38th Annual Meeting